These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

556 related items for PubMed ID: 10391881

  • 1. alpha-synuclein fibrillogenesis is nucleation-dependent. Implications for the pathogenesis of Parkinson's disease.
    Wood SJ, Wypych J, Steavenson S, Louis JC, Citron M, Biere AL.
    J Biol Chem; 1999 Jul 09; 274(28):19509-12. PubMed ID: 10391881
    [Abstract] [Full Text] [Related]

  • 2. Both familial Parkinson's disease mutations accelerate alpha-synuclein aggregation.
    Narhi L, Wood SJ, Steavenson S, Jiang Y, Wu GM, Anafi D, Kaufman SA, Martin F, Sitney K, Denis P, Louis JC, Wypych J, Biere AL, Citron M.
    J Biol Chem; 1999 Apr 02; 274(14):9843-6. PubMed ID: 10092675
    [Abstract] [Full Text] [Related]

  • 3. Accelerated in vitro fibril formation by a mutant alpha-synuclein linked to early-onset Parkinson disease.
    Conway KA, Harper JD, Lansbury PT.
    Nat Med; 1998 Nov 02; 4(11):1318-20. PubMed ID: 9809558
    [Abstract] [Full Text] [Related]

  • 4. Fibrils formed in vitro from alpha-synuclein and two mutant forms linked to Parkinson's disease are typical amyloid.
    Conway KA, Harper JD, Lansbury PT.
    Biochemistry; 2000 Mar 14; 39(10):2552-63. PubMed ID: 10704204
    [Abstract] [Full Text] [Related]

  • 5. Lipid droplet binding and oligomerization properties of the Parkinson's disease protein alpha-synuclein.
    Cole NB, Murphy DD, Grider T, Rueter S, Brasaemle D, Nussbaum RL.
    J Biol Chem; 2002 Feb 22; 277(8):6344-52. PubMed ID: 11744721
    [Abstract] [Full Text] [Related]

  • 6. The alpha-synucleinopathies: Parkinson's disease, dementia with Lewy bodies, and multiple system atrophy.
    Spillantini MG, Goedert M.
    Ann N Y Acad Sci; 2000 Feb 22; 920():16-27. PubMed ID: 11193145
    [Abstract] [Full Text] [Related]

  • 7. Aggregation of alpha-synuclein in the pathogenesis of Parkinson's disease.
    Iwatsubo T.
    J Neurol; 2003 Oct 22; 250 Suppl 3():III11-4. PubMed ID: 14579119
    [Abstract] [Full Text] [Related]

  • 8. Synphilin-1 is present in Lewy bodies in Parkinson's disease.
    Wakabayashi K, Engelender S, Yoshimoto M, Tsuji S, Ross CA, Takahashi H.
    Ann Neurol; 2000 Apr 22; 47(4):521-3. PubMed ID: 10762166
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Binding of alpha-synuclein to brain vesicles is abolished by familial Parkinson's disease mutation.
    Jensen PH, Nielsen MS, Jakes R, Dotti CG, Goedert M.
    J Biol Chem; 1998 Oct 09; 273(41):26292-4. PubMed ID: 9756856
    [Abstract] [Full Text] [Related]

  • 12. Effect of familial Parkinson's disease point mutations A30P and A53T on the structural properties, aggregation, and fibrillation of human alpha-synuclein.
    Li J, Uversky VN, Fink AL.
    Biochemistry; 2001 Sep 25; 40(38):11604-13. PubMed ID: 11560511
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Alpha synuclein is present in Lewy bodies in sporadic Parkinson's disease.
    Mezey E, Dehejia AM, Harta G, Tresser N, Suchy SF, Nussbaum RL, Brownstein MJ, Polymeropoulos MH.
    Mol Psychiatry; 1998 Nov 25; 3(6):493-9. PubMed ID: 9857974
    [Abstract] [Full Text] [Related]

  • 15. [Parkinson's disease, dementia with Lewy bodies, multiple system atrophy and alpha-synuclein].
    Iwatsubo T.
    Rinsho Shinkeigaku; 1999 Dec 25; 39(12):1285-6. PubMed ID: 10791099
    [Abstract] [Full Text] [Related]

  • 16. Human alpha-synuclein-harboring familial Parkinson's disease-linked Ala-53 --> Thr mutation causes neurodegenerative disease with alpha-synuclein aggregation in transgenic mice.
    Lee MK, Stirling W, Xu Y, Xu X, Qui D, Mandir AS, Dawson TM, Copeland NG, Jenkins NA, Price DL.
    Proc Natl Acad Sci U S A; 2002 Jun 25; 99(13):8968-73. PubMed ID: 12084935
    [Abstract] [Full Text] [Related]

  • 17. [The mechanism of Lewy body formation in Parkinson's disease].
    Wakabayashi K, Takahashi H.
    Nihon Rinsho; 2000 Oct 25; 58(10):2022-7. PubMed ID: 11068441
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Extensive axonal Lewy neurites in Parkinson's disease: a novel pathological feature revealed by alpha-synuclein immunocytochemistry.
    Braak H, Sandmann-Keil D, Gai W, Braak E.
    Neurosci Lett; 1999 Apr 09; 265(1):67-9. PubMed ID: 10327208
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 28.